Mostrar registro simples

dc.contributor.authorPilati, Natália Pasetopt_BR
dc.contributor.authorZanatta, Maria Alexandrinapt_BR
dc.contributor.authorMaltauro, Daniele Camilapt_BR
dc.contributor.authorBehenck, Gabriellept_BR
dc.contributor.authorValério, Edimárlei Gonsalespt_BR
dc.contributor.authorCastilhos, Fernanda Oliveirapt_BR
dc.contributor.authorStuczynski, Eduardo Vettorazzipt_BR
dc.contributor.authorVettori, Daniela Vanessapt_BR
dc.contributor.authorVettorazzi, Janetept_BR
dc.date.accessioned2021-12-22T04:27:38Zpt_BR
dc.date.issued2021pt_BR
dc.identifier.issn2160-8806pt_BR
dc.identifier.urihttp://hdl.handle.net/10183/233244pt_BR
dc.description.abstractA pregnant woman diagnosed with type 1 angioedema seeks care at a public hospital for planning the delivery. This report presents ways to prevent and manage an acute HAE crisis during childbirth and early postpartum without the availability of first-line medications, such as plasma-derived human C1-INH concentrate.en
dc.format.mimetypeapplication/pdfpt_BR
dc.language.isoengpt_BR
dc.relation.ispartofOpen journal of obstetrics and gynecology. Irvine. Vol. 11, no. 11(2021), p. 1470-1476.pt_BR
dc.rightsOpen Accessen
dc.subjectMulherespt_BR
dc.subjectHereditary angioedemaen
dc.subjectHAEen
dc.subjectGravidezpt_BR
dc.subjectC1-inhibitoren
dc.subjectAngioedemas hereditáriospt_BR
dc.subjectHigh-risk pregnancyen
dc.subjectGravidez de alto riscopt_BR
dc.subjectPrevenção de doençaspt_BR
dc.subjectProphylaxisen
dc.titleHereditary angioedema in pregnancy and management without recombinant human C1-INHpt_BR
dc.typeArtigo de periódicopt_BR
dc.identifier.nrb001134093pt_BR
dc.type.originEstrangeiropt_BR


Thumbnail
   

Este item está licenciado na Creative Commons License

Mostrar registro simples